Does the addition of recLH (Luveris) to a regimen of recFSH (Gonal-F) and GnRH antagonist (Cetrotide) improve ovarian response and implantation rates in patients age >35 years undergoing IVF/ET?
- Conditions
- Subfertile women undergoing IVF or ICSI, age > 35 years
- Registration Number
- NL-OMON29497
- Lead Sponsor
- VU University Medical Center, Devision of Reproductive Medicine
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
Age >35 years undergoing IVF or ICSI for any indication.
Exclusion Criteria
Women with PCOS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method